MA53541B1 - Dérivés hétéroaryles bicycliques - Google Patents
Dérivés hétéroaryles bicycliquesInfo
- Publication number
- MA53541B1 MA53541B1 MA53541A MA53541A MA53541B1 MA 53541 B1 MA53541 B1 MA 53541B1 MA 53541 A MA53541 A MA 53541A MA 53541 A MA53541 A MA 53541A MA 53541 B1 MA53541 B1 MA 53541B1
- Authority
- MA
- Morocco
- Prior art keywords
- bicyclic heteroaryl
- heteroaryl derivatives
- compounds
- methods
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
L'invention concerne de nouveaux composés hétéroaryles bicycliques de formule générale (i), dans laquelle r1, ar, n et m sont tels que décrits dans la description, des compositions comprenant les composés, des procédés de fabrication des composés et des procédés d'utilisation des composés.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18192219 | 2018-09-03 | ||
| PCT/EP2019/073303 WO2020048904A1 (fr) | 2018-09-03 | 2019-09-02 | Dérivés hétéroaryles bicycliques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA53541A MA53541A (fr) | 2021-12-08 |
| MA53541B1 true MA53541B1 (fr) | 2024-02-29 |
Family
ID=63490310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA53541A MA53541B1 (fr) | 2018-09-03 | 2019-09-02 | Dérivés hétéroaryles bicycliques |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US12084461B2 (fr) |
| EP (1) | EP3846903B1 (fr) |
| JP (1) | JP7398435B2 (fr) |
| KR (1) | KR20210054515A (fr) |
| CN (1) | CN112566696B (fr) |
| AR (1) | AR116051A1 (fr) |
| AU (1) | AU2019336492B2 (fr) |
| BR (1) | BR112021002170A2 (fr) |
| CA (1) | CA3107593A1 (fr) |
| CL (1) | CL2021000486A1 (fr) |
| CO (1) | CO2021002415A2 (fr) |
| CR (1) | CR20210104A (fr) |
| DK (1) | DK3846903T3 (fr) |
| ES (1) | ES2966947T3 (fr) |
| FI (1) | FI3846903T3 (fr) |
| HR (1) | HRP20231663T1 (fr) |
| HU (1) | HUE064554T2 (fr) |
| IL (1) | IL281175B2 (fr) |
| LT (1) | LT3846903T (fr) |
| MA (1) | MA53541B1 (fr) |
| MX (1) | MX2021002087A (fr) |
| PE (1) | PE20210860A1 (fr) |
| PH (1) | PH12021550320A1 (fr) |
| PL (1) | PL3846903T3 (fr) |
| PT (1) | PT3846903T (fr) |
| RS (1) | RS64950B1 (fr) |
| SG (1) | SG11202102137SA (fr) |
| SI (1) | SI3846903T1 (fr) |
| TW (1) | TWI841592B (fr) |
| UA (1) | UA128482C2 (fr) |
| WO (1) | WO2020048904A1 (fr) |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5994349A (en) | 1997-10-27 | 1999-11-30 | Howard University | 3-carboalkoxy-2, 3-dihydro-1H-phenothiazin-4[10H]-one derivatives |
| HU229993B1 (en) | 1998-04-01 | 2015-04-28 | Cardiome Pharma Corp | Aminocyclohexyl ether compounds and uses thereof |
| AU2528900A (en) | 1999-02-12 | 2000-08-29 | Nortran Pharmaceuticals Inc. | Cycloalkyl amine compounds and uses thereof |
| US7507545B2 (en) | 1999-03-31 | 2009-03-24 | Cardiome Pharma Corp. | Ion channel modulating activity method |
| US6448246B1 (en) | 1999-05-25 | 2002-09-10 | Neurogen Corporation | Substituted 4H-1,4-benzothiazine-2-carboxamide: GABA brain receptor ligands |
| AU775102B2 (en) | 1999-09-13 | 2004-07-15 | David M. Swope | Composition and method for decreasing neurologic symptomatology |
| US7057053B2 (en) | 2000-10-06 | 2006-06-06 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
| WO2007032009A2 (fr) | 2005-09-15 | 2007-03-22 | Biomas Ltd. | Utilisation de composes tellures pour le traitement du carcinome basocellulaire et/ou de la keratose actinique |
| MX2009012163A (es) | 2007-05-11 | 2009-12-01 | Hoffmann La Roche | Hetarilanilinas como moduladores para beta-amiloide. |
| CN101903347B (zh) | 2007-10-19 | 2013-03-27 | 詹森药业有限公司 | 带哌啶基和哌嗪基的γ-分泌酶调节剂 |
| MX2011005046A (es) | 2008-11-13 | 2011-06-01 | Schering Corp | Moduladores de gamma secretasa. |
| RU2515976C2 (ru) | 2009-02-26 | 2014-05-20 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Азотсодержащие конденсированные гетероциклические соединения и их применение в качестве ингибиторов продукции бета-амилоида |
| WO2010138901A1 (fr) | 2009-05-29 | 2010-12-02 | Biogen Idec Ma Inc | Composés contenant de l'acide carboxylique, leurs dérivés et procédés d'utilisation associés |
| JPWO2011007756A1 (ja) * | 2009-07-13 | 2012-12-27 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
| CN102484127B (zh) | 2009-09-04 | 2015-07-15 | 惠普开发有限公司 | 基于混合金属价键化合物的记忆电阻 |
| US20110190269A1 (en) | 2010-02-01 | 2011-08-04 | Karlheinz Baumann | Gamma secretase modulators |
| US8486967B2 (en) | 2010-02-17 | 2013-07-16 | Hoffmann-La Roche Inc. | Heteroaryl substituted piperidines |
| US8703763B2 (en) | 2011-03-02 | 2014-04-22 | Hoffmann-La Roche Inc. | Bridged piperidine derivatives |
| CA2841102C (fr) | 2011-07-15 | 2019-08-13 | Janssen Pharmaceuticals, Inc. | Nouveaux derives d'indole substitues utilises en tant que modulateurs de la gamma-secretase |
| WO2014060112A1 (fr) | 2012-10-19 | 2014-04-24 | Origenis Gmbh | Pyrazolo[4,3-d]pyrimidines utiles en tant qu'inhibiteurs de kinases |
| JP6831372B2 (ja) | 2015-09-09 | 2021-02-17 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 架橋ピペリジン誘導体 |
| WO2017097728A1 (fr) | 2015-12-10 | 2017-06-15 | F. Hoffmann-La Roche Ag | Dérivés de pipéridine pontés |
| WO2018001918A1 (fr) | 2016-06-27 | 2018-01-04 | F. Hoffmann-La Roche Ag | Triazolopyridines en tant que modulateurs de gamma-sécrétase |
| AR109829A1 (es) * | 2016-09-29 | 2019-01-30 | Hoffmann La Roche | Derivados de piperidina puenteados |
| WO2018083050A1 (fr) * | 2016-11-01 | 2018-05-11 | F. Hoffmann-La Roche Ag | Dérivés hétéroaryle bicycliques |
| CN109790149B (zh) | 2016-11-08 | 2022-05-17 | 豪夫迈·罗氏有限公司 | 苯氧基三唑类化合物 |
| WO2018111926A2 (fr) | 2016-12-16 | 2018-06-21 | Inception 3, Inc. | Méthodes de traitement de la synaptopathie cochléaire |
| CN111417636B (zh) | 2018-01-22 | 2023-09-26 | 豪夫迈·罗氏有限公司 | 三唑并-氮杂䓬衍生物 |
-
2019
- 2019-09-02 AR ARP190102494A patent/AR116051A1/es unknown
- 2019-09-02 LT LTEPPCT/EP2019/073303T patent/LT3846903T/lt unknown
- 2019-09-02 WO PCT/EP2019/073303 patent/WO2020048904A1/fr active Application Filing
- 2019-09-02 EP EP19759411.2A patent/EP3846903B1/fr active Active
- 2019-09-02 UA UAA202101190A patent/UA128482C2/uk unknown
- 2019-09-02 RS RS20231189A patent/RS64950B1/sr unknown
- 2019-09-02 AU AU2019336492A patent/AU2019336492B2/en active Active
- 2019-09-02 PL PL19759411.2T patent/PL3846903T3/pl unknown
- 2019-09-02 CN CN201980054254.2A patent/CN112566696B/zh active Active
- 2019-09-02 BR BR112021002170-1A patent/BR112021002170A2/pt unknown
- 2019-09-02 ES ES19759411T patent/ES2966947T3/es active Active
- 2019-09-02 PT PT197594112T patent/PT3846903T/pt unknown
- 2019-09-02 US US17/273,278 patent/US12084461B2/en active Active
- 2019-09-02 MX MX2021002087A patent/MX2021002087A/es unknown
- 2019-09-02 SI SI201930682T patent/SI3846903T1/sl unknown
- 2019-09-02 JP JP2021512272A patent/JP7398435B2/ja active Active
- 2019-09-02 IL IL281175A patent/IL281175B2/en unknown
- 2019-09-02 PE PE2021000165A patent/PE20210860A1/es unknown
- 2019-09-02 HU HUE19759411A patent/HUE064554T2/hu unknown
- 2019-09-02 CA CA3107593A patent/CA3107593A1/fr active Pending
- 2019-09-02 FI FIEP19759411.2T patent/FI3846903T3/fi active
- 2019-09-02 HR HRP20231663TT patent/HRP20231663T1/hr unknown
- 2019-09-02 DK DK19759411.2T patent/DK3846903T3/da active
- 2019-09-02 CR CR20210104A patent/CR20210104A/es unknown
- 2019-09-02 KR KR1020217006240A patent/KR20210054515A/ko active Pending
- 2019-09-02 TW TW108131458A patent/TWI841592B/zh active
- 2019-09-02 SG SG11202102137SA patent/SG11202102137SA/en unknown
- 2019-09-02 MA MA53541A patent/MA53541B1/fr unknown
-
2021
- 2021-02-15 PH PH12021550320A patent/PH12021550320A1/en unknown
- 2021-02-24 CO CONC2021/0002415A patent/CO2021002415A2/es unknown
- 2021-02-26 CL CL2021000486A patent/CL2021000486A1/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA55131B1 (fr) | Nouveaux composés hétérocycliques | |
| MA49560B1 (fr) | Composés cétoniques bicycliques et leurs procédés d'utilisation | |
| MA51530B1 (fr) | Composés cycliques fondus | |
| MA38432B1 (fr) | Nouveaux dérivés d'octahydro-pyrrolo [3,4-c]-pyrrole et analogues de ceux-ci servant d'inhibiteurs d'autotaxine | |
| MA45223A (fr) | Nouveaux dérivés de pipéridinyle subsitués par (hétéro)aryle, leur procédé de préparation et compositions pharmaceutiques les contenant | |
| MA31741B1 (fr) | Derives fongicides de 2-alkylthio-2-quinolinyloxy- acetamide | |
| MA43639B1 (fr) | Nouveaux dérivés d'ammonium, procédé de préparation de ceux-ci et compositions pharmaceutiques les contenant | |
| MA30784B1 (fr) | Derives phenyliques et utilisation de ceux-ci en tant qu'immunomodulateurs. | |
| MA32104B1 (fr) | Dérivés d'oxime en tant qu'inhibiteurs de hsp90 | |
| MA31597B1 (fr) | Nouveaux herbicides | |
| TNSN07393A1 (fr) | Nouveaux ligands du recepteur h3 de l'histamine et leurs applications therapeutiques | |
| MA37942B1 (fr) | Hétéroaryldihydropyrimidines d'acide 6-aminé pour le traitement et la prophylaxie d'une infection par le virus de l'hépatite b | |
| MA41134A (fr) | Composés substitués de 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione pour le traitement et la prophylaxie des infections virales | |
| MA37756A1 (fr) | Nouveaux composés diazaspirocycloalcane et azaspirocycloalcane | |
| MA45222B1 (fr) | Nouveaux dérivés de pipéridinyle, procédé de préparation de ceux-ci et compositions pharmaceutiques les contenant | |
| MA30427B1 (fr) | Derives bicycliques utilises comme inhibiteurs de cetp | |
| HRP20070076A2 (en) | Pyrimidine derivatives | |
| MA31690B1 (fr) | Nouveaux fongicides | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| MA47085B1 (fr) | Polymorphes | |
| MA47081A (fr) | Polymorphes | |
| EA200600979A1 (ru) | Замещённые арилпиразолы в качестве противопаразитарных средств | |
| MA37384B1 (fr) | Nouveaux dérivés de thiénopyrimidine, leurs procédés de préparation et leurs utilisations thérapeutiques. | |
| MA32173B1 (fr) | Derives de pyridin-2-yle utilises comme agents immunomodulateurs | |
| MA38948B1 (fr) | Dérivés de 2h-indazole antibactériens |